ImmunoGen, Inc. (NASDAQ:IMGN) Q2 2023 Earnings Call Transcript
Operator: Good morning and welcome to ImmunoGen’s second quarter 2023 financial and operating results conference call. Today’s conference is being recorded.
Source: insidermonkey.com
Philipp Harter News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Philipp Harter. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Philipp Harter Today - Breaking & Trending Today
Durvalumab, Olaparib Combination Improves Progression-Free Survival in Patients With Advanced Ovarian Cancer
Positive findings in patients with advanced high-grade epithelial ovarian cancer were presented during an oral presentation at the 2023 American Society of Clinical Oncology Annual Meeting.
Source: pharmacytimes.com
New Combination Drug Reduces Risk of Disease Progression in Ovarian Cancer
Miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.
Source: miragenews.com
Imfinzi, Lynparza Combination Improves PFS in Patients With Ovarian Cancer in Phase 3 Trial
Individuals treated with the drugs from AstraZeneca demonstrate clinically meaningful and statistically significant improvement.
Source: pharmacytimes.com
Lynparza and Imfinzi combination improved progression-free survival in newly diagnosed patients with advanced ovarian cancer without tumour BRCA mutations in DUO-O Phase III trial
Positive high-level results from a planned interim analysis of the DUO-O Phase III trial showed treatment with a combination of Lynparza (olaparib
Source: nationaltribune.com.au